Glycosphingolipid synthesis inhibitor AMP-DNM lowers plasma cholesterol levels by promoting fecal cholesterol excretion without inhibiting cholesterol absorption

Publication Type:

Journal Article

Authors:

Vrins, C.L.J.; Bietrix, F.; Lombardo, E.; van Roomen, C.P.P.A.; Ottenhoff, R.; Overkleeft, H.S.; Aerts, J.M.

Source:

Clinical Lipidology, Volume 7, Number 2, p.241-248 (2012)

ISBN:

1758-4299

DOI Name (links to online publication)

10.2217/clp.12.14
05/06/2012